M
MYND Life Sciences Inc
CNSX:MYND
MYND Life Sciences Inc
CNSX:MYND
Price:
0.07
CAD
Market Closed
Market Cap:
CA$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
Income Statement
Earnings Waterfall
MYND Life Sciences Inc
MYND Life Sciences Inc
Income Statement
MYND Life Sciences Inc
MYND Life Sciences Inc
Currency: CAD
| Jan-2022 | Apr-2022 | Jul-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Jan-2024 | Apr-2024 | Jul-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
-33%
|
(0)
+25%
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(8)
|
(9)
|
(9)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(6)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Research & Development |
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(8)
N/A
|
(9)
-17%
|
(9)
+0%
|
(4)
+56%
|
(2)
+44%
|
(2)
+25%
|
(1)
+32%
|
(1)
+22%
|
(1)
-3%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(9)
-18%
|
(9)
+0%
|
(4)
+57%
|
(2)
+40%
|
(2)
+14%
|
(2)
+23%
|
(1)
+24%
|
(1)
+13%
|
|
| Net Income | ||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(9)
|
(9)
|
(4)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Net Income (Common) |
(7)
N/A
|
(9)
-19%
|
(9)
+0%
|
(4)
+56%
|
(2)
+40%
|
(2)
+14%
|
(2)
+23%
|
(1)
+24%
|
(1)
+13%
|
|
| EPS (Diluted) |
-0.16
N/A
|
-0.19
-19%
|
-0.19
N/A
|
-0.08
+58%
|
-0.05
+38%
|
-0.04
+20%
|
-0.03
+25%
|
-0.02
+33%
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
